MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,254 | -30.8% | 16,350 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $378,993 | -29.6% | 16,350 | -42.0% | 0.00% | 0.0% |
| Q3 2022 | $538,000 | +5.1% | 28,188 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $512,000 | -27.9% | 28,188 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $710,000 | -8.7% | 28,188 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $778,000 | -61.6% | 28,188 | -55.1% | 0.00% | -75.0% |
| Q3 2021 | $2,028,000 | +5.6% | 62,798 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,920,000 | +0.4% | 62,798 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,912,000 | +53.9% | 62,798 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $1,242,000 | +51.6% | 62,798 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $819,000 | +15.0% | 62,798 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $712,000 | -20.8% | 62,798 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $899,000 | -42.2% | 62,798 | +10.0% | 0.00% | -25.0% |
| Q4 2019 | $1,555,000 | – | 57,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $98,875,000 | 3.47% |
| Tieton Capital Management, LLC | 187,636 | $3,711,000 | 2.72% |
| Glenview Capital Management | 3,682,691 | $72,825,000 | 1.67% |
| Altium Capital Management LP | 218,650 | $4,324,000 | 1.61% |
| S&T BANK/PA | 331,098 | $6,547,000 | 1.18% |
| EARNEST PARTNERS LLC | 6,731,429 | $133,114,000 | 0.92% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,078,075 | $41,094,000 | 0.79% |
| SummerHaven Investment Management, LLC | 35,700 | $706,000 | 0.55% |
| AIMZ Investment Advisors, LLC | 42,685 | $844,000 | 0.44% |
| CONTINENTAL ADVISORS LLC | 36,392 | $720,000 | 0.33% |